Biotech · Private company
Kiniksa Pharmaceuticals International, plc
Track this companyFree. Adds Kiniksa Pharmaceuticals International, plc to your Dealase workspace and tells you when its record changes.
Clinical trials53 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- KPL-387Phase 3 · PericarditisClinicalTrials.gov · fetched Nov 12, 2026
- mavrilimumabPhase 3 · COVIDClinicalTrials.gov · fetched Nov 12, 2026
- AbiprubartPhase 2 · Sjögrens DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- KPL-387Phase 2 · Recurrent PericarditisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Transition to KPL-387 Monotherapy Dosing & Administration StudyPHASE2 · RECRUITING · started Mar 25, 2026ClinicalTrials.gov NCT07288216 · fetched Nov 12, 2026
- Phase 2/3 Study of Participants With Recurrent Pericarditis Evaluating the Efficacy and Safety of KPL-387PHASE2_PHASE3 · RECRUITING · started Jul 25, 2025ClinicalTrials.gov NCT07010159 · fetched Nov 12, 2026
- A Study to Evaluate the Efficacy and Safety of Abiprubart in Participants With Sjögren's DiseasePHASE2 · TERMINATED · started Jul 17, 2024ClinicalTrials.gov NCT06531395 · fetched Nov 12, 2026
- REgiStry Of the NAtural History of recurreNt periCarditis in pEdiatric and Adult PatientsACTIVE_NOT_RECRUITING · started Mar 16, 2021ClinicalTrials.gov NCT04687358 · fetched Nov 12, 2026
- Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammationPHASE2_PHASE3 · COMPLETED · started Jul 28, 2020ClinicalTrials.gov NCT04447469 · fetched Nov 12, 2026